| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/01/2005 | US6861418 Modulating protein kinase signal transduction; anticancer agents |
| 03/01/2005 | US6861417 Such as 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazine for treating cytokine mediated diseases such as psoriatic arthritis |
| 03/01/2005 | US6861416 New intermediates and synthetic methods for the stereospecific synthesis of oxazinone compounds, which are useful, for example, as antibiotics. The invention also pertains to novel olefinic oxazinone compounds, methods for |
| 03/01/2005 | US6861412 Diphosphate salt of A 4″-substituted-9-deoxo-9A-AZA-9A-homoerythromycin derivative and its pharmaceutical composition |
| 03/01/2005 | US6861409 Compounds for use in the dtreatment of growth metabolic disorders |
| 03/01/2005 | US6861244 Inactivated influenza virus vaccine for nasal or oral application |
| 03/01/2005 | US6861072 Pharmaceutical composition with gastric residence and controlled release |
| 03/01/2005 | US6861071 Highly absorptive solid preparation |
| 03/01/2005 | US6861059 Administering DP-107 or a pharmaceutically acceptable derivative thereof along with at least one therapeutic agent; synergistic |
| 03/01/2005 | CA2390110C Modular transport systems for molecular substances and production and use thereof |
| 02/28/2005 | CA2479474A1 Polypeptides involved in fungal biofilm formation and polynucleotides encoding same, and uses thereof |
| 02/24/2005 | WO2005017129A1 Phosphoramide and uses thereof |
| 02/24/2005 | WO2005017124A2 Peptide deformylase inhibitors |
| 02/24/2005 | WO2005017093A2 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | WO2005016942A1 Organophosphoric 4-iminohydantoin derivatives |
| 02/24/2005 | WO2005016932A1 Pyranobenzothiophene derivatives to treat infection with hepatitis c virus |
| 02/24/2005 | WO2005016929A1 Fused heterocylcles as inhibitors of glutamate racemase (muri) |
| 02/24/2005 | WO2005016927A1 Nitrogenous condensed-ring compound and use thereof as hiv integrase inhibitor |
| 02/24/2005 | WO2005016919A1 Aminopyrones and their use as atm inhibitors |
| 02/24/2005 | WO2005016916A2 Substituted quinolines serving as antimicrobial agents |
| 02/24/2005 | WO2005016911A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | WO2005016386A1 Improved therapeutic protocols |
| 02/24/2005 | WO2005016375A1 C1-inh as a drug for treating viruses pathogenic to humans |
| 02/24/2005 | WO2005016370A1 Method of treating viral infections |
| 02/24/2005 | WO2005016288A2 Methods and compositions for treatment of viral diseases |
| 02/24/2005 | WO2005015983A1 Method for the on-land production of red algae from the bonnemaisoniaceae family |
| 02/24/2005 | WO2004108745A3 11-12 bicyclic erythromycin derivatives |
| 02/24/2005 | WO2004087195A3 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 02/24/2005 | WO2004075907A9 Salutary compositions consisting of fungi containing lipids and thiocyanates |
| 02/24/2005 | WO2004037163A3 STERICALLY-AWKWARD β-LACTAMASE INHIBITORS |
| 02/24/2005 | WO2004024088A3 Design of chemokine analogs for the treatment of human diseases |
| 02/24/2005 | WO2004015062A3 Methods and compositions relating to gene silencing |
| 02/24/2005 | WO2004009020A3 Pyrrolopyrimidine thionucleoside analogs as antivirals |
| 02/24/2005 | WO2003099851A3 Methods and compositions for inhibiting hiv replication |
| 02/24/2005 | US20050043545 4-(5-Membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 02/24/2005 | US20050043540 such as cis-4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]-N-methyl-N-(3-phenyl-2(E)-propenyl)-benzenemethanamine; |
| 02/24/2005 | US20050043536 Sulfonamides |
| 02/24/2005 | US20050043528 Enterococcus faecalis polynucleotides and polypeptides |
| 02/24/2005 | US20050043509 Peptoid compounds |
| 02/24/2005 | US20050043399 Dimeric compounds and their use as anti-viral agents |
| 02/24/2005 | US20050043394 For prophylaxis and therapy of diabetes mellitus, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases, neuropathic diseases, neuropathic pain and polyneuropathy; free fatty acids and/or fatty acid esters and uridine, deoxyuridine, uridine monophosphate, deoxyuridine monophosphate |
| 02/24/2005 | US20050043393 Antilipemic agents |
| 02/24/2005 | US20050043390 Viricides against herpes virus |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043374 Administering to animal drug , or hydrolysable ester thereof |
| 02/24/2005 | US20050043369 Bactericidal antimicrobial methods and compositions for use in treating gram positive infections |
| 02/24/2005 | US20050043352 human YAK family of serine/threonine protein kinases (hyak); use treating diseases of the hematopoietic systems, including anemias, polycythemia, myelodysplastic syndrome, myelosuppression, cytopenia, male contraceptives; 2-(3-Chloro-phenylamino)-7-methoxy-quinoline-3-carboxylic acid for example |
| 02/24/2005 | US20050043346 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/24/2005 | US20050043340 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 02/24/2005 | US20050043333 Quinazolinone derivative |
| 02/24/2005 | US20050043330 Antiinflammation agents |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050043289 cephalosporins; antimicrobial agent |
| 02/24/2005 | US20050043269 Pharmaceutically active uridine esters |
| 02/24/2005 | US20050043268 Inhibition of viruses |
| 02/24/2005 | US20050043222 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042729 Expression vector comprising nucleotide sequences conding immunoglobulin/interferon fusion for use in targeting and treatment of liver disorders |
| 02/24/2005 | US20050042667 Expression vector comprising nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of immune, hematopoietic, inflammatory and tumor diseases |
| 02/24/2005 | US20050042317 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 02/24/2005 | US20050042313 Method to enhance the immune system and used for the prevention and treatment of infectious diseases |
| 02/24/2005 | US20050042308 Soft capsules containing mint oil with analgesics, antiinflammatory agents ; complex |
| 02/24/2005 | US20050042299 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 02/24/2005 | US20050042237 Method for administering a spill resistant pharmaceutical system |
| 02/24/2005 | US20050042236 Plant extract active as an immunostimulating agent |
| 02/24/2005 | US20050042235 Borrelia burgdorferi bacterin |
| 02/24/2005 | US20050042226 Treatment of chronic human viral hepatitis |
| 02/24/2005 | US20050042208 Incubating precursor cell capable of differentiating to cytotoxic T cell with antigen presenting cell in presence of substance having binding activity to CD44, fibronectin, regulator of signal emitted by growth factor, and/or inhibitor of binding to growth factor receptor; immunotherapy |
| 02/24/2005 | US20050042202 Gentamicin, amikacin, tobramycin, netilmicin, cephalosporin, ceftazidine, maxalactam, carbopenem, imipenem, aztreonam, ampicillin, penicillin, ureidopenicillin, augmentin, amphotericin, famvir and/or acyclovir; and Vpr protein, fragment or nucleic acid encoding; systemic inflammatory response syndrome |
| 02/24/2005 | DE10333192A1 Pharmazeutischer Wirkstoff gegen Warzen, Herpes simplex und Herpes zoster Active pharmaceutical ingredient against warts, herpes simplex and herpes zoster |
| 02/24/2005 | CA2577239A1 Nitrogen-containing fused ring compound and use thereof as hiv integraseinhibitor |
| 02/24/2005 | CA2536235A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/24/2005 | CA2535984A1 C1-inh as a drug for treating viruses pathogenic to humans |
| 02/24/2005 | CA2535863A1 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | CA2535619A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | CA2535451A1 Method of treating viral infections |
| 02/24/2005 | CA2535020A1 Substituted quinolines serving as antimicrobial agents |
| 02/24/2005 | CA2534300A1 Aminopyrones and their use as atm inhibitors |
| 02/24/2005 | CA2526339A1 Polyvalent immunogen |
| 02/24/2005 | CA2525647A1 Synthetic chemokine receptor ligands and methods of use thereof |
| 02/24/2005 | CA2525228A1 Molecules enhancing dermal delivery of influenza vaccines |
| 02/23/2005 | EP1508335A1 Composition against periodontal bacteria and foods, drinks and mouth washers against periodontal bacteria containing the composition |
| 02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
| 02/23/2005 | EP1507850A1 A method for generating antigen-presenting cells |
| 02/23/2005 | EP1507799A2 Novel cyclic peptides and use thereof as anti-microbial agents |
| 02/23/2005 | EP1507796A1 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/23/2005 | EP1507794A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/23/2005 | EP1507791A2 Antisense antiviral agent and method for treating ssrna viral infection |
| 02/23/2005 | EP1507780A1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| 02/23/2005 | EP1507779A1 Inhibitors of jak and cdk2 protein kinases |
| 02/23/2005 | EP1507773A1 Macrocyclic compounds useful as pharmaceuticals |
| 02/23/2005 | EP1507758A2 Indole derivatives and their use as ligands for cb2 receptors |
| 02/23/2005 | EP1507757A1 Lactams used as anti-viral agents |
| 02/23/2005 | EP1507545A1 A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere |
| 02/23/2005 | EP1507544A1 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 02/23/2005 | EP1507539A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
| 02/23/2005 | EP1507535A1 Pyrimidine-2,4,6-trione metallo-proteinase inhibitors |
| 02/23/2005 | EP1507532A2 Use of quinoline derivatives with anti-integrase effect and applications thereof |
| 02/23/2005 | EP1507528A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting |